The Potential Economic Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation Modeling.

Amir Abbas Tahami MonfaredAli TafazzoliAmeya ChavanWeicheng YeQuanwu Zhang

Published in: Neurology and therapy (2022)

The early model predicted that lecanemab would potentially improve long-term health outcomes and reduce formal and informal care costs, resulting in a range of VBPs that reflect the value of lecanemab to society.

Keyphrases

healthcare
palliative care
quality improvement
pain management
human health
life cycle